insights_auto
Why is GUTS down 10.97%?
Dive Deeperchevron_right
GUTS:NASDAQ
Fractyl Health
$1.38
arrow_downward
-10.97%(-0.17) 1D
$1.37
arrow_downward
-0.72% (-0.0100)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUTS...
Open
$1.44
High
$1.52
Low
$1.37
Mkt. cap
18.31M
Avg. vol.
1.78M
Volume
1.15M
52-wk high
$29.34
52-wk low
$1.37
EPS
-$13.43
Shares outstanding
13.26M
No. of employees
100
Open
$1.44
High
$1.52
Low
$1.37
Mkt. cap
18.31M
Avg. vol.
1.78M
Volume
1.15M
52-wk high
$29.34
52-wk low
$1.37
EPS
-$13.43
Shares outstanding
13.26M
No. of employees
100
News stories
From web sources and news partners
TradingView
·
2 hours ago
Moore Law PLLC Seeks Fractyl Health Investors After Stock Drop
kalkine.ca
·
10 hours ago
Why Fractyl Health (NASDAQ: GUTS) Stock Plunged 63% Despite Meeting Its REMAIN-1 Primary Endpoint
Timothy Sykes
·
1 day ago
Fractyl Health Stock Collapses As GUTS Faces Class Action Over Revita Data
Timothy Sykes
·
2 days ago
GUTS Stock Plunges As Fractyl Health Faces Securities Lawsuit
Profile
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1. Wikipedia
About Fractyl Health
CEO-
Employees100
Founded2010
HeadquartersBurlington, Massachusetts, United States
SectorMedical device
Websitefractyl.com